XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.3

SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table presents segment revenue and significant segment expenses (in thousands) for the three and nine months ended September 30, 2025 and 2024:

			THREE MONTHS ENDED SEPTEMBER 30,												NINE MONTHS ENDED SEPTEMBER 30,
			2025						2024						2025						2024
REVENUE:
Total segment revenue			14,262						388						243,676						508
LESS:
KER-065 program expenses			(1,345)						(4,935)						(4,293)						(12,225)
Elritercept program expenses			(3,341)						(13,576)						(37,872)						(33,161)
Cibotercept program expenses			(1,218)						(8,618)						(11,185)						(20,820)
Preclinical & development expenses			(1,700)						(4,206)						(5,425)						(10,322)
Compensation costs (excluding stock based compensation)			(9,568)						(11,830)						(37,187)						(35,186)
Stock-based compensation			(3,986)						(8,817)						(21,391)						(25,672)
Depreciation expense			(395)						(315)						(1,109)						(897)
Other segment items2			(8,346)						(6,840)						(29,187)						(20,529)
Dividend income			6,933						5,793						20,845						16,977
Income tax (provision) benefit			1,424						—						(6,397)						—
Net income (loss)			(7,280)						(52,956)						110,475						(141,327)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration